 | • レポートコード：QFJ1-4548 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、医療用ナノテクノロジーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ナノメディシン、ナノ医療機器、ナノ診断、その他）、用途別市場規模（抗がん剤、CNS製品、抗感染症、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・医療用ナノテクノロジーの市場動向 ・企業の競争状況、市場シェア ・医療用ナノテクノロジーの種類別市場規模と予測2016-2027（ナノメディシン、ナノ医療機器、ナノ診断、その他） ・医療用ナノテクノロジーの用途別市場規模と予測2016-2027（抗がん剤、CNS製品、抗感染症、その他） ・医療用ナノテクノロジーの北米市場規模2016-2027（アメリカ、カナダ） ・医療用ナノテクノロジーの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・医療用ナノテクノロジーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・医療用ナノテクノロジーの中南米市場規模2016-2027（メキシコ、ブラジル） ・医療用ナノテクノロジーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、Teva Pharmaceuticals、Abbott、UCB、Roche、Celgene、Sanofi、Merck & Co、Biogen、Stryker、Gilead Sciences、Pfizer、3M Company、Johnson & Johnson、Smith & Nephew、Leadiant Biosciences、Kyowa Hakko Kirin、Shire、Ipsen、Endo International） ・結論 |
It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
Market Analysis and Insights: Global Nanotechnology for Healthcare Market
The global Nanotechnology for Healthcare market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nanotechnology for Healthcare market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nanotechnology for Healthcare market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nanotechnology for Healthcare market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nanotechnology for Healthcare market.
Global Nanotechnology for Healthcare Scope and Market Size
Nanotechnology for Healthcare market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nanotechnology for Healthcare market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Segment by Application
Anticancer
CNS Product
Anti-infective
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanotechnology for Healthcare Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nanomedicine
1.2.3 Nano Medical Devices
1.2.4 Nano Diagnosis
1.2.5 Other
1.3 Market by Application
1.3.1 Global Nanotechnology for Healthcare Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Anticancer
1.3.3 CNS Product
1.3.4 Anti-infective
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nanotechnology for Healthcare Market Perspective (2016-2027)
2.2 Nanotechnology for Healthcare Growth Trends by Regions
2.2.1 Nanotechnology for Healthcare Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nanotechnology for Healthcare Historic Market Share by Regions (2016-2021)
2.2.3 Nanotechnology for Healthcare Forecasted Market Size by Regions (2022-2027)
2.3 Nanotechnology for Healthcare Industry Dynamic
2.3.1 Nanotechnology for Healthcare Market Trends
2.3.2 Nanotechnology for Healthcare Market Drivers
2.3.3 Nanotechnology for Healthcare Market Challenges
2.3.4 Nanotechnology for Healthcare Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanotechnology for Healthcare Players by Revenue
3.1.1 Global Top Nanotechnology for Healthcare Players by Revenue (2016-2021)
3.1.2 Global Nanotechnology for Healthcare Revenue Market Share by Players (2016-2021)
3.2 Global Nanotechnology for Healthcare Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nanotechnology for Healthcare Revenue
3.4 Global Nanotechnology for Healthcare Market Concentration Ratio
3.4.1 Global Nanotechnology for Healthcare Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanotechnology for Healthcare Revenue in 2020
3.5 Nanotechnology for Healthcare Key Players Head office and Area Served
3.6 Key Players Nanotechnology for Healthcare Product Solution and Service
3.7 Date of Enter into Nanotechnology for Healthcare Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanotechnology for Healthcare Breakdown Data by Type
4.1 Global Nanotechnology for Healthcare Historic Market Size by Type (2016-2021)
4.2 Global Nanotechnology for Healthcare Forecasted Market Size by Type (2022-2027)
5 Nanotechnology for Healthcare Breakdown Data by Application
5.1 Global Nanotechnology for Healthcare Historic Market Size by Application (2016-2021)
5.2 Global Nanotechnology for Healthcare Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Nanotechnology for Healthcare Market Size (2016-2027)
6.2 North America Nanotechnology for Healthcare Market Size by Type
6.2.1 North America Nanotechnology for Healthcare Market Size by Type (2016-2021)
6.2.2 North America Nanotechnology for Healthcare Market Size by Type (2022-2027)
6.2.3 North America Nanotechnology for Healthcare Market Size by Type (2016-2027)
6.3 North America Nanotechnology for Healthcare Market Size by Application
6.3.1 North America Nanotechnology for Healthcare Market Size by Application (2016-2021)
6.3.2 North America Nanotechnology for Healthcare Market Size by Application (2022-2027)
6.3.3 North America Nanotechnology for Healthcare Market Size by Application (2016-2027)
6.4 North America Nanotechnology for Healthcare Market Size by Country
6.4.1 North America Nanotechnology for Healthcare Market Size by Country (2016-2021)
6.4.2 North America Nanotechnology for Healthcare Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nanotechnology for Healthcare Market Size (2016-2027)
7.2 Europe Nanotechnology for Healthcare Market Size by Type
7.2.1 Europe Nanotechnology for Healthcare Market Size by Type (2016-2021)
7.2.2 Europe Nanotechnology for Healthcare Market Size by Type (2022-2027)
7.2.3 Europe Nanotechnology for Healthcare Market Size by Type (2016-2027)
7.3 Europe Nanotechnology for Healthcare Market Size by Application
7.3.1 Europe Nanotechnology for Healthcare Market Size by Application (2016-2021)
7.3.2 Europe Nanotechnology for Healthcare Market Size by Application (2022-2027)
7.3.3 Europe Nanotechnology for Healthcare Market Size by Application (2016-2027)
7.4 Europe Nanotechnology for Healthcare Market Size by Country
7.4.1 Europe Nanotechnology for Healthcare Market Size by Country (2016-2021)
7.4.2 Europe Nanotechnology for Healthcare Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Nanotechnology for Healthcare Market Size (2016-2027)
8.2 Asia-Pacific Nanotechnology for Healthcare Market Size by Type
8.2.1 Asia-Pacific Nanotechnology for Healthcare Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nanotechnology for Healthcare Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nanotechnology for Healthcare Market Size by Type (2016-2027)
8.3 Asia-Pacific Nanotechnology for Healthcare Market Size by Application
8.3.1 Asia-Pacific Nanotechnology for Healthcare Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nanotechnology for Healthcare Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nanotechnology for Healthcare Market Size by Application (2016-2027)
8.4 Asia-Pacific Nanotechnology for Healthcare Market Size by Region
8.4.1 Asia-Pacific Nanotechnology for Healthcare Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nanotechnology for Healthcare Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nanotechnology for Healthcare Market Size (2016-2027)
9.2 Latin America Nanotechnology for Healthcare Market Size by Type
9.2.1 Latin America Nanotechnology for Healthcare Market Size by Type (2016-2021)
9.2.2 Latin America Nanotechnology for Healthcare Market Size by Type (2022-2027)
9.2.3 Latin America Nanotechnology for Healthcare Market Size by Type (2016-2027)
9.3 Latin America Nanotechnology for Healthcare Market Size by Application
9.3.1 Latin America Nanotechnology for Healthcare Market Size by Application (2016-2021)
9.3.2 Latin America Nanotechnology for Healthcare Market Size by Application (2022-2027)
9.3.3 Latin America Nanotechnology for Healthcare Market Size by Application (2016-2027)
9.4 Latin America Nanotechnology for Healthcare Market Size by Country
9.4.1 Latin America Nanotechnology for Healthcare Market Size by Country (2016-2021)
9.4.2 Latin America Nanotechnology for Healthcare Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanotechnology for Healthcare Market Size (2016-2027)
10.2 Middle East & Africa Nanotechnology for Healthcare Market Size by Type
10.2.1 Middle East & Africa Nanotechnology for Healthcare Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nanotechnology for Healthcare Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nanotechnology for Healthcare Market Size by Type (2016-2027)
10.3 Middle East & Africa Nanotechnology for Healthcare Market Size by Application
10.3.1 Middle East & Africa Nanotechnology for Healthcare Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nanotechnology for Healthcare Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nanotechnology for Healthcare Market Size by Application (2016-2027)
10.4 Middle East & Africa Nanotechnology for Healthcare Market Size by Country
10.4.1 Middle East & Africa Nanotechnology for Healthcare Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nanotechnology for Healthcare Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Nanotechnology for Healthcare Introduction
11.1.4 Amgen Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Teva Pharmaceuticals
11.2.1 Teva Pharmaceuticals Company Details
11.2.2 Teva Pharmaceuticals Business Overview
11.2.3 Teva Pharmaceuticals Nanotechnology for Healthcare Introduction
11.2.4 Teva Pharmaceuticals Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.2.5 Teva Pharmaceuticals Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Nanotechnology for Healthcare Introduction
11.3.4 Abbott Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 UCB
11.4.1 UCB Company Details
11.4.2 UCB Business Overview
11.4.3 UCB Nanotechnology for Healthcare Introduction
11.4.4 UCB Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.4.5 UCB Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Nanotechnology for Healthcare Introduction
11.5.4 Roche Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Celgene
11.6.1 Celgene Company Details
11.6.2 Celgene Business Overview
11.6.3 Celgene Nanotechnology for Healthcare Introduction
11.6.4 Celgene Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.6.5 Celgene Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Nanotechnology for Healthcare Introduction
11.7.4 Sanofi Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Merck & Co
11.8.1 Merck & Co Company Details
11.8.2 Merck & Co Business Overview
11.8.3 Merck & Co Nanotechnology for Healthcare Introduction
11.8.4 Merck & Co Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.8.5 Merck & Co Recent Development
11.9 Biogen
11.9.1 Biogen Company Details
11.9.2 Biogen Business Overview
11.9.3 Biogen Nanotechnology for Healthcare Introduction
11.9.4 Biogen Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.9.5 Biogen Recent Development
11.10 Stryker
11.10.1 Stryker Company Details
11.10.2 Stryker Business Overview
11.10.3 Stryker Nanotechnology for Healthcare Introduction
11.10.4 Stryker Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.10.5 Stryker Recent Development
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Details
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Nanotechnology for Healthcare Introduction
11.11.4 Gilead Sciences Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.11.5 Gilead Sciences Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Nanotechnology for Healthcare Introduction
11.12.4 Pfizer Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.12.5 Pfizer Recent Development
11.13 3M Company
11.13.1 3M Company Company Details
11.13.2 3M Company Business Overview
11.13.3 3M Company Nanotechnology for Healthcare Introduction
11.13.4 3M Company Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.13.5 3M Company Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Nanotechnology for Healthcare Introduction
11.14.4 Johnson & Johnson Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.14.5 Johnson & Johnson Recent Development
11.15 Smith & Nephew
11.15.1 Smith & Nephew Company Details
11.15.2 Smith & Nephew Business Overview
11.15.3 Smith & Nephew Nanotechnology for Healthcare Introduction
11.15.4 Smith & Nephew Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.15.5 Smith & Nephew Recent Development
11.16 Leadiant Biosciences
11.16.1 Leadiant Biosciences Company Details
11.16.2 Leadiant Biosciences Business Overview
11.16.3 Leadiant Biosciences Nanotechnology for Healthcare Introduction
11.16.4 Leadiant Biosciences Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.16.5 Leadiant Biosciences Recent Development
11.17 Kyowa Hakko Kirin
11.17.1 Kyowa Hakko Kirin Company Details
11.17.2 Kyowa Hakko Kirin Business Overview
11.17.3 Kyowa Hakko Kirin Nanotechnology for Healthcare Introduction
11.17.4 Kyowa Hakko Kirin Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.17.5 Kyowa Hakko Kirin Recent Development
11.18 Shire
11.18.1 Shire Company Details
11.18.2 Shire Business Overview
11.18.3 Shire Nanotechnology for Healthcare Introduction
11.18.4 Shire Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.18.5 Shire Recent Development
11.18 Ipsen
.1 Ipsen Company Details
.2 Ipsen Business Overview
.3 Ipsen Nanotechnology for Healthcare Introduction
.4 Ipsen Revenue in Nanotechnology for Healthcare Business (2016-2021)
.5 Ipsen Recent Development
11.20 Endo International
11.20.1 Endo International Company Details
11.20.2 Endo International Business Overview
11.20.3 Endo International Nanotechnology for Healthcare Introduction
11.20.4 Endo International Revenue in Nanotechnology for Healthcare Business (2016-2021)
11.20.5 Endo International Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Nanotechnology for Healthcare Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nanomedicine
Table 3. Key Players of Nano Medical Devices
Table 4. Key Players of Nano Diagnosis
Table 5. Key Players of Other
Table 6. Global Nanotechnology for Healthcare Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Nanotechnology for Healthcare Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Nanotechnology for Healthcare Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Nanotechnology for Healthcare Market Share by Regions (2016-2021)
Table 10. Global Nanotechnology for Healthcare Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Nanotechnology for Healthcare Market Share by Regions (2022-2027)
Table 12. Nanotechnology for Healthcare Market Trends
Table 13. Nanotechnology for Healthcare Market Drivers
Table 14. Nanotechnology for Healthcare Market Challenges
Table 15. Nanotechnology for Healthcare Market Restraints
Table 16. Global Nanotechnology for Healthcare Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Nanotechnology for Healthcare Market Share by Players (2016-2021)
Table 18. Global Top Nanotechnology for Healthcare Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanotechnology for Healthcare as of 2020)
Table 19. Ranking of Global Top Nanotechnology for Healthcare Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Nanotechnology for Healthcare Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Nanotechnology for Healthcare Product Solution and Service
Table 23. Date of Enter into Nanotechnology for Healthcare Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nanotechnology for Healthcare Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Nanotechnology for Healthcare Revenue Market Share by Type (2016-2021)
Table 27. Global Nanotechnology for Healthcare Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Nanotechnology for Healthcare Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Nanotechnology for Healthcare Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Nanotechnology for Healthcare Revenue Market Share by Application (2016-2021)
Table 31. Global Nanotechnology for Healthcare Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Nanotechnology for Healthcare Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Nanotechnology for Healthcare Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Nanotechnology for Healthcare Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Nanotechnology for Healthcare Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Nanotechnology for Healthcare Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Nanotechnology for Healthcare Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Nanotechnology for Healthcare Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Nanotechnology for Healthcare Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Nanotechnology for Healthcare Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Nanotechnology for Healthcare Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Nanotechnology for Healthcare Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Nanotechnology for Healthcare Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Nanotechnology for Healthcare Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Nanotechnology for Healthcare Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Nanotechnology for Healthcare Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Nanotechnology for Healthcare Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Nanotechnology for Healthcare Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Nanotechnology for Healthcare Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Nanotechnology for Healthcare Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Nanotechnology for Healthcare Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Nanotechnology for Healthcare Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Nanotechnology for Healthcare Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Nanotechnology for Healthcare Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Nanotechnology for Healthcare Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Nanotechnology for Healthcare Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Nanotechnology for Healthcare Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Nanotechnology for Healthcare Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Nanotechnology for Healthcare Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Nanotechnology for Healthcare Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Nanotechnology for Healthcare Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Nanotechnology for Healthcare Market Size by Country (2022-2027) & (US$ Million)
Table 63. Amgen Company Details
Table 64. Amgen Business Overview
Table 65. Amgen Nanotechnology for Healthcare Product
Table 66. Amgen Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 67. Amgen Recent Development
Table 68. Teva Pharmaceuticals Company Details
Table 69. Teva Pharmaceuticals Business Overview
Table 70. Teva Pharmaceuticals Nanotechnology for Healthcare Product
Table 71. Teva Pharmaceuticals Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 72. Teva Pharmaceuticals Recent Development
Table 73. Abbott Company Details
Table 74. Abbott Business Overview
Table 75. Abbott Nanotechnology for Healthcare Product
Table 76. Abbott Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 77. Abbott Recent Development
Table 78. UCB Company Details
Table 79. UCB Business Overview
Table 80. UCB Nanotechnology for Healthcare Product
Table 81. UCB Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 82. UCB Recent Development
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche Nanotechnology for Healthcare Product
Table 86. Roche Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 87. Roche Recent Development
Table 88. Celgene Company Details
Table 89. Celgene Business Overview
Table 90. Celgene Nanotechnology for Healthcare Product
Table 91. Celgene Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 92. Celgene Recent Development
Table 93. Sanofi Company Details
Table 94. Sanofi Business Overview
Table 95. Sanofi Nanotechnology for Healthcare Product
Table 96. Sanofi Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 97. Sanofi Recent Development
Table 98. Merck & Co Company Details
Table 99. Merck & Co Business Overview
Table 100. Merck & Co Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 101. Merck & Co Recent Development
Table 102. Biogen Company Details
Table 103. Biogen Business Overview
Table 104. Biogen Nanotechnology for Healthcare Product
Table 105. Biogen Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 106. Biogen Recent Development
Table 107. Stryker Company Details
Table 108. Stryker Business Overview
Table 109. Stryker Nanotechnology for Healthcare Product
Table 110. Stryker Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 111. Stryker Recent Development
Table 112. Gilead Sciences Company Details
Table 113. Gilead Sciences Business Overview
Table 114. Gilead Sciences Nanotechnology for Healthcare Product
Table 115. Gilead Sciences Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 116. Gilead Sciences Recent Development
Table 117. Pfizer Company Details
Table 118. Pfizer Business Overview
Table 119. Pfizer Nanotechnology for Healthcare Product
Table 120. Pfizer Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 121. Pfizer Recent Development
Table 122. 3M Company Company Details
Table 123. 3M Company Business Overview
Table 124. 3M Company Nanotechnology for Healthcare Product
Table 125. 3M Company Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 126. 3M Company Recent Development
Table 127. Johnson & Johnson Company Details
Table 128. Johnson & Johnson Business Overview
Table 129. Johnson & Johnson Nanotechnology for Healthcare Product
Table 130. Johnson & Johnson Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 131. Johnson & Johnson Recent Development
Table 132. Smith & Nephew Company Details
Table 133. Smith & Nephew Business Overview
Table 134. Smith & Nephew Nanotechnology for Healthcare Product
Table 135. Smith & Nephew Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 136. Smith & Nephew Recent Development
Table 137. Leadiant Biosciences Company Details
Table 138. Leadiant Biosciences Business Overview
Table 139. Leadiant Biosciences Nanotechnology for Healthcare Product
Table 140. Leadiant Biosciences Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 141. Leadiant Biosciences Recent Development
Table 142. Kyowa Hakko Kirin Company Details
Table 143. Kyowa Hakko Kirin Business Overview
Table 144. Kyowa Hakko Kirin Nanotechnology for Healthcare Product
Table 145. Kyowa Hakko Kirin Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 146. Kyowa Hakko Kirin Recent Development
Table 147. Shire Company Details
Table 148. Shire Business Overview
Table 149. Shire Nanotechnology for Healthcare Product
Table 150. Shire Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 151. Shire Recent Development
Table 152. Ipsen Company Details
Table 153. Ipsen Business Overview
Table 154. Ipsen Nanotechnology for Healthcare Product
Table 155. Ipsen Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 156. Ipsen Recent Development
Table 157. Endo International Company Details
Table 158. Endo International Business Overview
Table 159. Endo International Nanotechnology for Healthcare Product
Table 160. Endo International Revenue in Nanotechnology for Healthcare Business (2016-2021) & (US$ Million)
Table 161. Endo International Recent Development
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanotechnology for Healthcare Market Share by Type: 2020 VS 2027
Figure 2. Nanomedicine Features
Figure 3. Nano Medical Devices Features
Figure 4. Nano Diagnosis Features
Figure 5. Other Features
Figure 6. Global Nanotechnology for Healthcare Market Share by Application: 2020 VS 2027
Figure 7. Anticancer Case Studies
Figure 8. CNS Product Case Studies
Figure 9. Anti-infective Case Studies
Figure 10. Other Case Studies
Figure 11. Nanotechnology for Healthcare Report Years Considered
Figure 12. Global Nanotechnology for Healthcare Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Nanotechnology for Healthcare Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Nanotechnology for Healthcare Market Share by Regions: 2020 VS 2027
Figure 15. Global Nanotechnology for Healthcare Market Share by Regions (2022-2027)
Figure 16. Global Nanotechnology for Healthcare Market Share by Players in 2020
Figure 17. Global Top Nanotechnology for Healthcare Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanotechnology for Healthcare as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Nanotechnology for Healthcare Revenue in 2020
Figure 19. Global Nanotechnology for Healthcare Revenue Market Share by Type (2016-2021)
Figure 20. Global Nanotechnology for Healthcare Revenue Market Share by Type (2022-2027)
Figure 21. North America Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Nanotechnology for Healthcare Market Share by Type (2016-2027)
Figure 23. North America Nanotechnology for Healthcare Market Share by Application (2016-2027)
Figure 24. North America Nanotechnology for Healthcare Market Share by Country (2016-2027)
Figure 25. United States Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Nanotechnology for Healthcare Market Share by Type (2016-2027)
Figure 29. Europe Nanotechnology for Healthcare Market Share by Application (2016-2027)
Figure 30. Europe Nanotechnology for Healthcare Market Share by Country (2016-2027)
Figure 31. Germany Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Nanotechnology for Healthcare Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Nanotechnology for Healthcare Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Nanotechnology for Healthcare Market Share by Region (2016-2027)
Figure 41. China Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Nanotechnology for Healthcare Market Share by Type (2016-2027)
Figure 49. Latin America Nanotechnology for Healthcare Market Share by Application (2016-2027)
Figure 50. Latin America Nanotechnology for Healthcare Market Share by Country (2016-2027)
Figure 51. Mexico Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Nanotechnology for Healthcare Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Nanotechnology for Healthcare Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Nanotechnology for Healthcare Market Share by Country (2016-2027)
Figure 57. Turkey Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Nanotechnology for Healthcare Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 61. Teva Pharmaceuticals Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 62. Abbott Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 63. UCB Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 65. Celgene Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 67. Merck & Co Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 68. Biogen Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 69. Stryker Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 70. Gilead Sciences Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 71. Pfizer Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 72. 3M Company Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 73. Johnson & Johnson Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 74. Smith & Nephew Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 75. Leadiant Biosciences Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 76. Kyowa Hakko Kirin Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 77. Shire Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 78. Ipsen Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 79. Endo International Revenue Growth Rate in Nanotechnology for Healthcare Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界の食品包装用ナノテクノロジー市場規模・現状・予測（2021年-2027年） Nanotechnology is the science of very small materials that has a big impact in food industry including packaging. A variety of nanomaterials such as silver nanoparticle, titanium nitride nanoparticle, and nano-titanium dioxide, nano-zince oxide, and nanoclay are introduced as functional additives to…- 航空機用ナノテクノロジーコーティング剤のグローバル市場2021 Nanotechnology is the science of making or working with things that are so small that they can only be seen using a powerful microscope. The top three companies, PPG, MDS Coating Technologies and Powdermet, have 47% of the market share. Market Analysis and Insights: Global Nanotechnology Enabled Coa…
- 世界のナノ材料＆ナノテクノロジー市場規模・現状・予測（2021年-2027年） Nanotechnology is the science and technology of making materials from a single atom or molecule, the properties and applications of materials with a structure size ranging from 1 to 100 nanometers are studied. Nanomaterials refer to materials that have a special property when the material is nanosca…
- 世界のナノ抗体市場規模・現状・予測（2021年-2027年） Nanoantibodies or "nAb" are single-domain VHH antibodies derived from camelidae (camels, llamas, alpacas, etc.). Compared with conventional monoclonal and polyclonal antibodies, nAbs have the following advantages: Small size (~15kd) High affinity (frequently nanomolar range) High specificity Unsurpa…
- 食品ナノテクノロジーのグローバル市場調査 2019年 The global Food Nanotechnology market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Food Nanotechnology volume and value at global level, regional level and company level. From a global perspective, this…